SCHEMBL1300079

SCHEMBL1300079

O=C1NC(=O)C(=Cc2ccc(OCCNC3CCCCC3)cc2)S1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 16/20 1.00
▸ PIM1 P11309 2/20 0.60
▸ PIM2 Q9P1W9 2/20 0.60
▸ HRH3 Q9Y5N1 1/20 0.58
▸ CISD1 Q9NZ45 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1300077 1.00 HPGD (1.00) HPGDPIM1PIM2HRH3CISD1
SCHEMBL1299638 0.83 HPGD (1.00) HPGDPIM1PIM2HRH3
SCHEMBL1299637 0.83 HPGD (1.00) HPGDPIM1PIM2HRH3
SCHEMBL1300303 0.82 HPGD (1.00) HPGD
SCHEMBL1300304 0.82 HPGD (1.00) HPGD
SCHEMBL1299961 0.81 HPGD (1.00) HPGD
SCHEMBL1299962 0.81 HPGD (1.00) HPGD
SCHEMBL934602 0.81 HPGD (1.00) HPGD
SCHEMBL934601 0.81 HPGD (1.00) HPGD
SCHEMBL1300311 0.80 HPGD (1.00) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2383263-B1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF UNIV CHOSUN IACF (KR) 2014-04-16 — — EP disclosed
US-8637558-B2 Thiazolidinedione derivative and use thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2014-01-28 — — US disclosed
US-20110269954-A1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2011-11-03 — — US disclosed
EP-2383263-A2 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF Industry-academic Cooperation Foundation, Chosun University (KR) 2011-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269954-A1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF HPGD, CYP27B1, GCDH HPGD 1/4885PIM1 4115/4885PIM2 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback